postoperative nausea and vomiting ponv continues to be one of the most common complaints following surgery occurring in more than 30 of surgeries or as high as 70 to 80 in certain highrisk populations without prophylaxisthe 5hydroxytryptamine type 3 5ht3 receptor antagonists continue to be the mainstay of antiemetic therapy but newer approaches such as neurokinin1 antagonists a longeracting serotonin receptor antagonist multimodal management and novel techniques for managing highrisk patients are gaining prominencethe related problem of postdischarge nausea and vomiting pdnv has received increasing attention from health care providersthe issues of ponv and pdnv are especially significant in the context of ambulatory surgeries which comprise more than 60 of the combined 564 million ambulatory and inpatient surgery visits in the united statesbecause of the relatively brief period that ambulatory patients spend in health care facilities it is particularly important to prevent and treat ponv and pdnv swiftly and effectivelycopyright c 2010published by elsevier inc